Return to symposium agenda
Scientific Symposium: 3 July 2010

Geneva, Switzerland
By Invitation Only

Speaker information
(listed in order of appearance)

Mark LeDoux
Natural Alternatives International, Inc.

Mark A. LeDoux, J.D., is founder/chief executive officer/chairman of Natural Alternatives International, Inc., (NAI) an organization with facilities in the U.S., Switzerland and Japan engaged in the research, design and manufacture of nutritional supplement programs and products for multinational clients. Mr. LeDoux is considered a leader and spokesperson for the nutritional supplements industry. He assumed chairmanship of the Council for Responsible Nutrition (CRN) in December 2008, serving through 2010, and is a member of the Board of Directors and Executive Committee of CRN.  He is a recognized participant of the Codex Alimentarius Commission, the United Nations’ food and dietary supplement standard-setting body under joint supervision of its Food and Agriculture Organization and World Health Organization. Mr. LeDoux is president of the Marie A. LeDoux Charitable Foundation and a member of the Young Presidents Organization Graduates.


Arpad Somogyi, D.V.M., Ph.D.
Consultant to the European Commission
Brussels, Belgium

During the past four decades Professor Somogyi participated as chairman, vice-chairman, raporteur, adviser and member of expert panels in countless national and international activities pertaining to risk assessment and risk management in the course of the safety evaluation of a large variety of products, processes and substances. On these subjects, he has authored more than 150 communications that appeared in international scientific periodicals or published as book chapters. In addition to his earned doctoral degrees he is holding two honorary doctorates and is a member of several learned societies, including an external membership of the Hungarian Academy of Sciences. Professor Somogyi served in the European Commission in Brussels where he became Head of the Unit Evaluation of Health Risks in the Directorate-General for Health and Consumer Protection. In 2002 he was entrusted by the European Commission with the EU Project Leadership aimed at establishing and developing the Hungarian Food Safety Office in Budapest. Since 1987 he has been serving as vice president of European Affairs of the Toxicology Forum.


Peter Prock, M.D.
European Nutraceutical Association
Basel, Switzerland

Dr. Peter Prock, a medical doctor focusing on preventive medicine, and scientific advisor for nutraceutical research and medical communications, is a founding member and current president of the European Nutraceutical Association, an expert association devoted to providing a scientific platform for nutraceuticals. He speaks and educates regularly on issues of preventive and lifestyle medicine, nutrition and nutritional supplements, weight management, hypertension and travel medicine and has been published in numerous peer-reviewed journals.


Hans-Konrad Biesalski, M.D., Ph.D.
University of Hohenheim, Stuttgart, Germany

Prof. Dr. Biesalski is currently head of the department of Biological Chemistry and Nutrition at the University of Hohenheim, a position he has held since1995. He serves on the boards of several scientific journals, including Nutrition, Nutrition and Metabolism, the International Journal of Vitamin and Nutrition Research, Aktuelle Ernährungsmedizin and the European Journal of Nutrition. He is a member of the executive board of the German Society of Nutrition Medicine, the scientific advisory board of the U.S. Pharmacopeia, the FAO/WHO Joint Expert Group on nanotechnology and food, and the scientific board of the German Society for Vitamin Research, among other key organizations. Prof. Dr. Biesalski has published more than 350 scientific papers in peer-reviewed journals.


Jeffrey Blumberg, Ph.D., F.A.C.N., F.A.S.N., C.N.S.
Tufts University, Boston, USA

Dr. Blumberg is a professor in the Friedman School of Nutrition Science and Policy and also serves as the director of the Antioxidants Research Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.  His research has focused on the biochemical basis for the role of antioxidant nutrients and their dietary requirements in promoting health and preventing disease during the aging process via changes in status of oxidative stress. He has published more than 265 scientific articles and serves on the editorial boards of several scientific journals.  Dr. Blumberg also participates in activities relevant to the incorporation of sound nutrition science into public health policy and has served as a member of the Surgeon General's Workshop on Health Promotion and Aging, Sports Medicine Committee of the U.S. Olympic Committee, WHO/FAO Consultation on Preparation and Use of Food-Based Dietary Guidelines, Food Advisory Committee of the U.S. FDA, and other committees.


Jean-Michel Antoine, M.D., Ph.D.
Danone Vitapole, Palaiseau, France

Dr. Jean-Michel Antoine is a physician by training, specializing in internal medicine, with a Ph.D. in Nutrition. He worked for ten years as resident and resident-in-chief in University hospitals in France before joining Danone in 1983 to create the department of Nutrition and implement clinical research on the effect of food on humans. Actively involved in ILSI Europe since its creation in 1986, he has contributed to many functional food projects. Dr. Antoine is one of the founding fathers of the European Nutrition Leadership Programme and has published more than 90 papers on nutrition and foods, many on probiotics.


John Hathcock, Ph.D.
Council for Responsible Nutrition (CRN)
Washington, D.C.,
USA

John Hathcock is senior vice president, Scientific & International Affairs atthe Council for Responsible Nutrition  (CRN) and is responsible for scientific review and regulatory interpretation, specializing in safety and international issues. He has decades of experience in the field, having served as a professor at Iowa State University and a senior scientist at the U.S. Food and Drug Administration (FDA) before joining CRN in 1995. An expert on the safety evaluation of nutrients and other dietary ingredients, he has made numerous presentations on the safety of vitamins and minerals and other dietary ingredients to the U.S. Food and Nutrition Board and is the author of CRN's Vitamin and Mineral Safety (1997 and 2004). In addition to publishing numerous peer-reviewed scientific articles, he regularly presents at major national and international conferences on food safety and regulatory issues, analyzes and develops CRN policy positions, and speaks on international regulations and issues, including those pertaining to the Codex Alimentarius, the European Commission, and the ASEAN health supplements harmonization of maximum levels. He has been appointed by the government of Singapore to membership in an external advisory committee on supplements.


Wolfgang Gaissmaier, Ph.D.
Max Planck Institute for Human Development, Berlin, Germany

Dr. Wolfgang Gaissmaier is chief research scientist at the Harding Center for Risk Literacy at the Max Planck Institute for Human Development, Berlin. In 2007, he finished his dissertation on how memory shapes decision making. His current research focuses on the intersection between basic research on decision making and memory and how it can be applied to medicine, health care, politics, finance and other (risky) domains. In particular, Dr. Gaissmaier is interested in cognitive and emotional mechanisms that explain how people make decisions under uncertainty and how they deal with risks. He has applied many principles investigated by the Harding Center in further education for physicians and entrepreneurs.


Corrado Galli, Ph.D.
University of Milan, Milan, Italy

Professor Galli’s professional studies and career have dynamically contributed both nationally and internationally to the promotion, continuous development and use of risk assessment using a robust scientific approach and strongly supported the use of mechanistic toxicology to improve the risk assessment process. In developing an original research program with emphasis on molecular and cellular mechanism for toxicity, including in vitro toxicology, Professor Galli has assisted numerous students and professionals in the field by demonstrating how exposure to chemicals causes adverse effects under various situations and in certain populations. His key research area includes exposure to low levels of chemicals in combination with other chemicals and environmental factors (i.e. food additives, food allergens, pesticides, contaminants) and use of state-of-the art molecular biology tools (genomics and proteomics) to facilitate research in the prediction of how the exposure to chemicals will affect the host. Professor Galli is author of more than 200 publications, and a member of numerous national and international scientific committees.


Gareth Edwards, B.Sc., M.Sc., FRSH
Gareth Edwards Consultancy, Reading, United Kingdom

Gareth Edwards has worked as an independent consultant since 2003, after 35 years in the food industry. He has considerable experience in the safety and regulatory issues associated with novel foods, and is currently an adviser to the ILSI Europe Task Force on Novel Foods and Nanotechnology and co-authored its paper on History of Safe Use. Mr. Edwards previously chaired the ILSI Europe Expert Group on the Safety Assessment of Novel Foods, which reported in 2003. He also sits on a number of food industry committees in the United Kingdom and Brussels, including the UK Food and Drink Federation’s Novel Foods Group. While working at the large UK food group RHM (now Premier Foods), he was responsible for Regulatory Affairs and Nutrition, providing advice to group companies on nutrition, food legislation and regulatory issues. During RHM’s development of mycoprotein, the first new food to obtain a formal approval in the UK, now sold under the brand name “Quorn,” Mr. Edwards was responsible for the safety evaluation and was heavily involved in obtaining regulatory approvals.